PIK3CA Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-98814APC
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for PIK3CA Antibody [Allophycocyanin]
Immunogen
Produced in rabbits immunized with a synthetic peptide corresponding to the C-terminus of the Human PIK3CA.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for PIK3CA Antibody [Allophycocyanin]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PIK3CA
Long Name
PI3-Kinase P110 Subunit Alpha
Alternate Names
CLAPO, CLOVE, CWS5, MCMTC, P110alpha, PI3Kalpha
Gene Symbol
PIK3CA
Additional PIK3CA Products
Product Documents for PIK3CA Antibody [Allophycocyanin]
Product Specific Notices for PIK3CA Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...